首页> 美国卫生研究院文献>Applied and Environmental Microbiology >In Vitro Activity of Lincomycin and Spectinomycin Against Serotypes of Avian Mycoplasma
【2h】

In Vitro Activity of Lincomycin and Spectinomycin Against Serotypes of Avian Mycoplasma

机译:林可霉素和大观霉素对禽支原体血清型的体外活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Twenty strains of avian mycoplasma, representing 12 serotypes, were tested in vitro for their susceptibility to the action of lincomycin and spectinomycin alone and in combination. They varied in their sensitivity pattern. The ranges of minimal inhibitory concentration were 1 to 20 μg/ml for lincomycin or spectinomycin alone and 0.5/1 to 3/6 μg/ml for the lincomycin and spectinomycin combination. The ranges of minimal lethal concentration were greater with either single antibiotic than with the antibiotic combination. The amount of each antibiotic required to achieve mycoplasmacidal action of the relatively resistant strains was less with the antibiotic combination than with the single antibiotics.
机译:在体外测试了代表12种血清型的20种禽支原体菌株对单独或联合使用林可霉素和壮观霉素的敏感性。他们的敏感性模式各不相同。最小抑制浓度的范围是:单独的林可霉素或壮观霉素为1至20μg/ ml,而对于林可霉素和壮观霉素组合,最低抑制浓度为0.5 / 1至3/6μg/ ml。两种抗生素相比,两种抗生素的最低致死浓度范围都更大。为达到相对抗性菌株的支原体酸作用所需的每种抗生素的量,与单一抗生素相比,使用抗生素组合的数量要少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号